Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Vigil Neuroscience, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 41 | 1 | 47 | +7 |
| Shares | 25.1M | 3.30K | 25.8M | +700.3K (+2.8%) |
| Value | $245.4M | $0 | $242.1M | −$3.34M (−1.4%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 48,488 | $455.8K | 0.00% |
| Charles Schwab Investment Management Inc | 41,968 | $394.5K | 0.00% |
| Nuveen Asset Management, LLC | 24,715 | $232.3K | 0.00% |
| Rhumbline Advisers | 16,358 | $153.8K | 0.00% |
| PEAK6 Investments LLC | 14,337 | $134.8K | 0.01% |
| JPMorgan Chase & Co | 12,805 | $120.4K | 0.00% |
| New York State Common Retirement Fund | 10,000 | $94.0K | 0.00% |
| MetLife Investment Management | 9,105 | $85.6K | 0.00% |
| American International Group, Inc. | 7,734 | $72.7K | 0.00% |
| California State Teachers Retirement System | 5,345 | $50.2K | 0.00% |
| Royal Bank of Canada | 3,499 | $33.0K | 0.00% |
| Amalgamated Bank | 1,563 | $15.0K | 0.00% |
| Legal & General Group Plc | 1,554 | $14.6K | 0.00% |
| Ameritas Investment Partners, Inc. | 1,327 | $12.5K | 0.00% |
| Metropolitan Life Insurance Co | 944 | $8.87K | 0.00% |
Sold out (8)
Institutions that held Vigil Neuroscience, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 71,381 | $699.0K |
| Susquehanna International Group, LLP | 58,718 | $574.8K |
| Jane Street Group, LLC | 27,184 | $266.1K |
| Qube Research & Technologies Ltd | 18,705 | $183.1K |
| 683 Capital Management, LLC | 15,092 | $147.8K |
| Man Group plc | – | $114.5K |
| Cannell Capital LLC | 8,044 | $78.8K |
| UBS Group AG | 592 | $5.80K |
Not filed for Q2 2023 yet (1)
Institutions that held Vigil Neuroscience, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Coppell Advisory Solutions Corp. | 3,298 | – |